Completed OBSERVATIONAL NCT04458701

Prospective Data Analysis of a Quality Improvement Initiative in High Risk Cardiac Surgery Patients

Prospective Data Analysis of a Quality Improvement Initiative for Perioperative Hemodynamic Optimization Therapy and Postoperative Outcomes in Patients Undergoing High-Risk Cardiac Surgery

Sponsor: Edwards Lifesciences

Conditions Coronary Artery Bypass Graft

Interventions Hemodynamic monitoring

Updated 5 times since 2020 Last updated: Aug 27, 2020 Started: Jan 17, 2019 Primary completion: Feb 1, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04458701, this observational or N/A phase trial focuses on Coronary Artery Bypass Graft and remains completed. Sponsored by Edwards Lifesciences, it has been updated 5 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Sep 2020 — Jan 2021 [monthly]

Completed
Aug 2020 — Sep 2020 [monthly]

Completed

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Edwards Lifesciences
Loma Linda University

Data source: Loma Linda University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Loma Linda, United States